Cargando…

Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling study

Community-based delivery and monitoring of antiretroviral therapy (ART) for HIV has the potential to increase viral suppression for individual- and population-level health benefits. However, the cost-effectiveness and budget impact are needed for public health policy. We used a mathematical model of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Maitreyi, Bayer, Cara J., Roberts, D. Allen, van Rooyen, Heidi, van Heerden, Alastair, Shahmanesh, Maryam, Asiimwe, Stephen, Sausi, Kombi, Sithole, Nsika, Ying, Roger, Rao, Darcy W., Krows, Meighan L., Shapiro, Adrienne E., Baeten, Jared M., Celum, Connie, Revill, Paul, Barnabas, Ruanne V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479912/
https://www.ncbi.nlm.nih.gov/pubmed/37669249
http://dx.doi.org/10.1371/journal.pgph.0000610
_version_ 1785101693909729280
author Sahu, Maitreyi
Bayer, Cara J.
Roberts, D. Allen
van Rooyen, Heidi
van Heerden, Alastair
Shahmanesh, Maryam
Asiimwe, Stephen
Sausi, Kombi
Sithole, Nsika
Ying, Roger
Rao, Darcy W.
Krows, Meighan L.
Shapiro, Adrienne E.
Baeten, Jared M.
Celum, Connie
Revill, Paul
Barnabas, Ruanne V.
author_facet Sahu, Maitreyi
Bayer, Cara J.
Roberts, D. Allen
van Rooyen, Heidi
van Heerden, Alastair
Shahmanesh, Maryam
Asiimwe, Stephen
Sausi, Kombi
Sithole, Nsika
Ying, Roger
Rao, Darcy W.
Krows, Meighan L.
Shapiro, Adrienne E.
Baeten, Jared M.
Celum, Connie
Revill, Paul
Barnabas, Ruanne V.
author_sort Sahu, Maitreyi
collection PubMed
description Community-based delivery and monitoring of antiretroviral therapy (ART) for HIV has the potential to increase viral suppression for individual- and population-level health benefits. However, the cost-effectiveness and budget impact are needed for public health policy. We used a mathematical model of HIV transmission in KwaZulu-Natal, South Africa, to estimate population prevalence, incidence, mortality, and disability-adjusted life-years (DALYs) from 2020 to 2060 for two scenarios: 1) standard clinic-based HIV care and 2) five-yearly home testing campaigns with community ART for people not reached by clinic-based care. We parameterised model scenarios using observed community-based ART efficacy. Using a health system perspective, we evaluated incremental cost-effectiveness and net health benefits using a threshold of $750/DALY averted. In a sensitivity analysis, we varied the discount rate; time horizon; costs for clinic and community ART, hospitalisation, and testing; and the proportion of the population receiving community ART. Uncertainty ranges (URs) were estimated across 25 best-fitting parameter sets. By 2060, community ART following home testing averted 27.9% (UR: 24.3–31.5) of incident HIV infections, 27.8% (26.8–28.8) of HIV-related deaths, and 18.7% (17.9–19.7) of DALYs compared to standard of care. Adolescent girls and young women aged 15–24 years experienced the greatest reduction in incident HIV (30.7%, 27.1–34.7). In the first five years (2020–2024), community ART required an additional $44.9 million (35.8–50.1) annually, representing 14.3% (11.4–16.0) of the annual HIV budget. The cost per DALY averted was $102 (85–117) for community ART compared with standard of care. Providing six-monthly refills instead of quarterly refills further increased cost-effectiveness to $78.5 per DALY averted (62.9–92.8). Cost-effectiveness was robust to sensitivity analyses. In a high-prevalence setting, scale-up of decentralised ART dispensing and monitoring can provide large population health benefits and is cost-effective in preventing death and disability due to HIV.
format Online
Article
Text
id pubmed-10479912
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-104799122023-09-06 Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling study Sahu, Maitreyi Bayer, Cara J. Roberts, D. Allen van Rooyen, Heidi van Heerden, Alastair Shahmanesh, Maryam Asiimwe, Stephen Sausi, Kombi Sithole, Nsika Ying, Roger Rao, Darcy W. Krows, Meighan L. Shapiro, Adrienne E. Baeten, Jared M. Celum, Connie Revill, Paul Barnabas, Ruanne V. PLOS Glob Public Health Research Article Community-based delivery and monitoring of antiretroviral therapy (ART) for HIV has the potential to increase viral suppression for individual- and population-level health benefits. However, the cost-effectiveness and budget impact are needed for public health policy. We used a mathematical model of HIV transmission in KwaZulu-Natal, South Africa, to estimate population prevalence, incidence, mortality, and disability-adjusted life-years (DALYs) from 2020 to 2060 for two scenarios: 1) standard clinic-based HIV care and 2) five-yearly home testing campaigns with community ART for people not reached by clinic-based care. We parameterised model scenarios using observed community-based ART efficacy. Using a health system perspective, we evaluated incremental cost-effectiveness and net health benefits using a threshold of $750/DALY averted. In a sensitivity analysis, we varied the discount rate; time horizon; costs for clinic and community ART, hospitalisation, and testing; and the proportion of the population receiving community ART. Uncertainty ranges (URs) were estimated across 25 best-fitting parameter sets. By 2060, community ART following home testing averted 27.9% (UR: 24.3–31.5) of incident HIV infections, 27.8% (26.8–28.8) of HIV-related deaths, and 18.7% (17.9–19.7) of DALYs compared to standard of care. Adolescent girls and young women aged 15–24 years experienced the greatest reduction in incident HIV (30.7%, 27.1–34.7). In the first five years (2020–2024), community ART required an additional $44.9 million (35.8–50.1) annually, representing 14.3% (11.4–16.0) of the annual HIV budget. The cost per DALY averted was $102 (85–117) for community ART compared with standard of care. Providing six-monthly refills instead of quarterly refills further increased cost-effectiveness to $78.5 per DALY averted (62.9–92.8). Cost-effectiveness was robust to sensitivity analyses. In a high-prevalence setting, scale-up of decentralised ART dispensing and monitoring can provide large population health benefits and is cost-effective in preventing death and disability due to HIV. Public Library of Science 2023-09-05 /pmc/articles/PMC10479912/ /pubmed/37669249 http://dx.doi.org/10.1371/journal.pgph.0000610 Text en © 2023 Sahu et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Sahu, Maitreyi
Bayer, Cara J.
Roberts, D. Allen
van Rooyen, Heidi
van Heerden, Alastair
Shahmanesh, Maryam
Asiimwe, Stephen
Sausi, Kombi
Sithole, Nsika
Ying, Roger
Rao, Darcy W.
Krows, Meighan L.
Shapiro, Adrienne E.
Baeten, Jared M.
Celum, Connie
Revill, Paul
Barnabas, Ruanne V.
Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling study
title Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling study
title_full Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling study
title_fullStr Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling study
title_full_unstemmed Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling study
title_short Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling study
title_sort population health impact, cost-effectiveness, and affordability of community-based hiv treatment and monitoring in south africa: a health economics modelling study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479912/
https://www.ncbi.nlm.nih.gov/pubmed/37669249
http://dx.doi.org/10.1371/journal.pgph.0000610
work_keys_str_mv AT sahumaitreyi populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT bayercaraj populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT robertsdallen populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT vanrooyenheidi populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT vanheerdenalastair populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT shahmaneshmaryam populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT asiimwestephen populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT sausikombi populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT sitholensika populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT yingroger populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT raodarcyw populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT krowsmeighanl populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT shapiroadriennee populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT baetenjaredm populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT celumconnie populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT revillpaul populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy
AT barnabasruannev populationhealthimpactcosteffectivenessandaffordabilityofcommunitybasedhivtreatmentandmonitoringinsouthafricaahealtheconomicsmodellingstudy